News | July 08, 2022
WuXi STA opens Oligonucleotide and Peptide manufacturing facility
Site Enhances New Modality CRDMO Platform Capacity for Customers
Site Enhances New Modality CRDMO Platform Capacity for Customers
Addition of Pepscan with its peptide discovery, lead optimization and GMP manufacturing capabilities provides end-to-end offering to Biosynth Carbosynth’s peptide customers.
The 41,000 sq ft facility will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
The investigational compound, GZR18, is a novel analogue of glucagon-like peptide-1 (GLP-1), an incretin hormone responsible for many glucoregulatory effects
ICICI Securities expects Hemmo to grow its revenue at a CAGR of 30.0% over FY21E-FY23E
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
Enabling a new era in minimally invasive obesity treatment across Europe
Syngene International has reported total income of Rs. 926 crore during the period ended September 30, 2025
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
Subscribe To Our Newsletter & Stay Updated
